Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

NGSX Insider Trading

NGSX | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at NGSX provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2011-08-12 13:04 2011-08-09 Arkin Moshe 10% owner, Other SELL $2.08 163,468 $339,752 0 -100.0%
2011-08-11 17:38 2011-08-09 BREEN DORON Other SELL $2.08 163,468 $339,752 0 -100.0%
2011-07-27 03:54 2011-07-26 NELSEN ROBERT Director, 10% owner BUY $1.65 1,744,186 $2,877,907 4,187,777 +71.4%
2011-07-26 04:09 2011-07-21 ARCH VENTURE FUND V LP 10% owner BUY $1.65 1,744,186 $2,877,907 4,187,777 +71.4%
2011-06-28 15:54 2011-06-24 BREEN DORON Other SELL $2.10 8,578 $18,024 163,468 -5.0%
2011-06-28 15:50 2011-06-24 Arkin Moshe 10% owner, Other SELL $2.10 8,578 $18,024 163,468 -5.0%
2011-06-27 15:33 2011-06-23 BREEN DORON Other SELL $2.09 50,000 $104,535 172,046 -22.5%
2011-06-27 15:35 2011-06-23 Arkin Moshe 10% owner, Other SELL $2.09 50,000 $104,535 172,046 -22.5%
2011-06-20 14:57 2011-06-16 BREEN DORON Other SELL $3.14 399,002 $1,253,265 222,046 -64.2%
2011-06-20 15:38 2011-06-16 Arkin Moshe 10% owner, Other SELL $3.20 300,000 $961,380 222,046 -57.5%
2011-06-06 15:19 2011-06-02 BREEN DORON Other SELL $2.34 21,107 $49,422 209,629 -9.1%
2011-06-02 16:52 2011-06-01 BREEN DORON Other SELL $2.46 11,000 $27,024 227,354 -4.6%
2011-05-19 23:19 2011-05-17 Tobias Jeffrey K Officer - EVP Research & Dev & CMO SELL $2.77 2,448 $6,783 4,999 -32.9%
2011-05-17 04:05 2011-05-12 Tobias Jeffrey K Officer - EVP Research & Dev & CMO SELL $2.85 2,666 $7,591 7,447 -26.4%
2011-05-11 02:24 2011-05-06 Ghiglieri Stephen F Officer - EVP, COO & CFO BUY $3.03 6,100 $18,466 2,500 +100.0%
2011-03-30 16:50 2011-03-28 BREEN DORON Other SELL $4.07 12,316 $50,137 236,264 -5.0%
2011-03-28 19:05 2011-03-24 BREEN DORON Other SELL $4.03 152,600 $615,558 522,046 -22.6%
2011-03-28 19:03 2011-03-24 Arkin Moshe 10% owner, Other SELL $4.03 152,600 $615,558 522,046 -22.6%
2011-03-26 01:03 2011-03-23 BREEN DORON Other SELL $4.01 33,800 $135,433 674,646 -4.8%
2011-03-26 01:01 2011-03-23 Arkin Moshe 10% owner, Other SELL $4.01 12,100 $48,537 674,646 -1.8%
2010-09-13 18:30 2010-09-09 Arkin Moshe 10% owner, Other BUY $5.50 30,000 $165,000 2,648,107 +1.1%
2010-08-20 22:22 2010-08-19 Markels Michael Officer - Senior VP,Commercial & Bus Dev BUY $5.75 2,500 $14,370 21,805 +13.0%
2010-08-11 20:47 2010-08-10 Goodwin Bradford S Director BUY $6.03 5,000 $30,155 15,000 +50.0%
2010-07-29 18:23 2009-12-03 BREEN DORON Other BUY $7.77 208,839 $1,622,387 270,498 +338.7%
2010-07-29 18:20 2009-11-11 BREEN DORON Other SELL $8.32 26,385 $219,647 35,287 -42.8%
2010-07-29 18:20 2009-09-11 BREEN DORON Other BUY $8.34 434,412 $3,620,998 57,087 +100.0%
2010-07-29 18:12 2010-01-25 Arkin Moshe 10% owner, Other BUY $7.23 162,024 $1,171,758 686,746 +30.9%
2010-07-29 18:09 2009-09-11 Arkin Moshe 10% owner, Other BUY $7.92 1,444,836 $11,439,778 2,495,304 +137.5%
2010-06-09 22:08 2010-06-07 Goodwin Bradford S Director BUY $7.27 10,000 $72,734 10,000 +100.0%
2010-05-21 20:14 2010-05-19 BIENAIME JEAN JACQUES Director SELL $8.71 1,500 $13,065 12,121 -11.0%
2010-05-05 22:56 2010-05-03 SVLSF IV, LLC 10% owner SELL $10.25 300,000 $3,075,000 61,324 -83.0%
2009-12-02 02:53 2009-11-30 Tobias Jeffrey K Officer - Chief Medical Officer OPT+S $8.07 12,077 $97,494 6,665 0.0%
2009-12-01 04:38 2009-11-25 Tobias Jeffrey K Officer - Chief Medical Officer OPT+S $8.38 9,923 $83,106 6,665 0.0%
2009-11-23 21:33 2009-11-19 BIENAIME JEAN JACQUES Director SELL $8.28 6,000 $49,667 13,621 -30.6%
2009-09-17 23:19 2009-09-15 SVLSF IV, LLC 10% owner SELL $8.00 1,845,000 $14,760,000 69,606 -96.4%
2009-08-22 02:19 2009-08-20 BIENAIME JEAN JACQUES Director SELL $7.22 1,000 $7,221 19,621 -4.8%
2009-08-18 02:36 2009-08-14 BIENAIME JEAN JACQUES Director SELL $7.25 6,740 $48,835 20,621 -24.6%
2009-08-14 23:00 2009-08-12 BIENAIME JEAN JACQUES Director SELL $7.39 5,661 $41,836 27,361 -17.1%
2009-07-15 23:30 2009-07-13 Flynn James E 10% owner, Other SELL $5.97 250,152 $1,493,407 987,880 -20.2%
2009-07-11 00:23 2009-07-08 Flynn James E 10% owner, Other SELL $5.92 23,694 $140,359 1,150,480 -2.0%
2009-07-09 00:27 2009-07-06 Flynn James E 10% owner, Other SELL $5.93 54,450 $323,046 1,165,883 -4.5%
2009-07-02 01:19 2009-06-26 Flynn James E 10% owner, Other SELL $5.87 275,313 $1,615,371 1,201,277 -18.6%
2009-06-25 17:01 2009-06-22 Flynn James E 10% owner, Other SELL $6.24 83,327 $520,185 1,379,713 -5.7%
2008-12-12 23:11 2008-12-10 BIENAIME JEAN JACQUES Director BUY $1.67 200 $335 33,022 +0.6%
2008-12-11 21:48 2008-12-09 Markels Michael Officer - VP, Commercial Ops and Bus Dev BUY $1.50 96 $144 15,645 +0.6%
2008-12-11 21:48 2008-12-10 Ghiglieri Stephen F Officer - Chief Financial Officer BUY $1.67 500 $834 38,419 +1.3%
2008-12-10 01:32 2008-12-05 BIENAIME JEAN JACQUES Director BUY $1.74 3,400 $5,921 32,822 +11.6%
2008-12-09 02:03 2008-12-04 Markels Michael Officer - VP, Commercial Ops and Bus Dev BUY $1.66 2,000 $3,310 15,549 +14.8%
2008-12-04 00:19 2008-12-01 Ghiglieri Stephen F Officer - Chief Financial Officer BUY $1.47 2,864 $4,213 37,919 +8.2%
2008-12-04 02:38 2008-12-01 BIENAIME JEAN JACQUES Director BUY $1.27 1,601 $2,035 29,422 +5.8%
SHOW ENTRIES

How to Interpret $NGSX Trades

Not every insider transaction in NGSX is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $NGSX shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for NGSX

Insider activity data for NGSX is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $NGSX, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.